Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus

The former generation of valves, the balloon expandable (Sapien XT), was associated to less paravalvular leak than the self-expanding valves only in patients with larger annuli. The new generation of self-expanding valves (Evolut R) has managed to significantly improve sealing in patients with larger annuli and still holds potential benefits for smaller annuli.

Centera Valvula expandibleThe aim of this study was to compare self-expanding vs. balloon expandable valves in patients with large and small annuli.

 

Patients with severe aortic stenosis requiring transcatheter aortic valve replacement were randomized and included in the CHOICE (Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: Medtronic CoreValve vs Edwards SAPIEN XT) trial (CoreValve n=120; SAPIEN XT n=121) and later in the non-randomized CHOICE-Extend registry that included patients with new generation versions of both valves (Evolut R n=100; SAPIEN 3, n=334).


Read also: In Diabetics with Multivessel Disease SYNTAX Score Calculations Are Redundant.


These compared performance by echocardiography in all patients and by cardiac magnetic resonance imaging regurgitant fraction only in a subgroup of patients. Patients were stratified according to aortic valve annular mean diameter into those with large (>23 mm) or small (≤23 mm) annuli.

 

Prosthesis percentage oversizing was 19.1 ± 6.4% with Core Valve, 11.4 ± 7.0% with XT, 18.8 ± 4.8% with Evolut R and 3.7 ± 5.5% with Sapien 3.

 

Mean gradient resulted lower both with Core Valve and Evolut R compared against XT or Sapien 3. This happened with both big and small annuli.


Read also: Infrainguinal Bypass Following Failed Endovascular Intervention Has a Different Outcome.


In the CHOICE trial, moderate or severe paravalvular leak was higher with the Core Valve than with XT in patients with large annuli (Eco 15.1% vs. 0.0%; p=0.002 and regurgitant fraction by MRI of 10.5% vs. 4.4; p=0.036), but this different was not significant in patients with small annuli.

 

In the CHOICE-Extend registry, moderate to severe paravalvular leak resulted similar between Evolut R and Sapien 3 both for big and small annuli.

 

Original title: After Transcatheter Aortic Valve Replacement with Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli. Insights from the CHOICE Trial and the CHOICE-Extend Registry.

Reference: Mohammad Abdelghani et al. J Am Coll Cardiol Intv 2018, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...